ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Study Links Native American Ancestry to Leukemia Relapse

February 25, 2011

UICC Receives 1300 Abstracts For Congress In Oslo, Norway.

February 22, 2002

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

Latest State Cancer Statistics Released.

January 14, 2005

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978